Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1997-01-10
1999-03-30
Ketter, James
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 29, C12Q 168
Patent
active
058887350
ABSTRACT:
Checkpoint gene-defective human cells are useful for screening potential anti-tumor agents. Potential therapeutic agents are screened for the ability to cause DNA accumulation or cell death in a checkpoint gene-defective human cell.
REFERENCES:
Brugarolas, "Radiation-induced Cell Cycle Arrest Compromised By p21 Deficiency," Nature 377:522-557 (1995).
Deng, "Mice Lacking p21.sup.CIP1/WAF1 Undergo Normal Development, But Are Defective in G1 Checkpoint Control," Cell, 82:675-684 (1959).
Gao, "Somatic Mutations of the WAF1/CIP1 Gene in Primary Prostate Cancer," Oncogene, 11, 1395-1398 (1995).
Gorczyca, "Detection of DNA Strand Breaks in Individual Apoptotic Cells by the in Situ Terminal Deoxynucleotidyl Transferase and Nick Translation Assays," Cancer Research, 53:1945-1951 (1993).
Hotz, Changes in Nuclear Chromating Related in Apoptosis or Necrosis Induced by the DNA Topoisomerase II Inhibitor Fostriecin in MOLT-4 and HL-60 Cells are Revealed by Altered DNA Sensitivity to Denaturation, Exp. Cell Research, 201:184-191 (1992).
Hunter, Cyclins and CancerII: Cyclin D and CDK Inhibitors Come of Age, Cell, 79:573-582 (1994).
Kung, "Cell Line-Specific Difference in the Control of Cell Cycle Progression in the Absence of Mitosis," Cell Biology, 87:9553-9557.
Sheer, "Inhibitors of Mammalian G, Cyclin-Dependent Kinaser," Genes & Development, 9:1149-1163 (1995).
Swat, "Detection of Apoptosis of Immature CD4+8+Thymocytes by Flow Cytometry," J. Immunol. Meth. 137:79-87 (1991).
Woods, "Taxol-Induced Mitotic Block Triggers Rapid Onset of a p53-Independent Apoptotic Pathway," Molecular Medicine, 1:506-526 (1995).
Little et al. The Journal of Biological Chemistry, vol. 270, No. 19, pp. 11033-11036, May 12, 1995.
Girinsky et al. Cancer Research. vol. 55, pp. 3726-3731, Sep. 1, 1995.
Vidal et al. Melanoma Research. vol. 5, pp. 243-250, Aug. 1995.
Waldman et al. Cancer Research, vol. 55, pp. 5187-5190 (Nov. 15, 1995).
Kinzler Kenneth W.
Lengauer Christoph
Vogelstein Bert
Waldman Todd
Ketter James
The Johns Hopkins University
Yucel Irem
LandOfFree
Cancer drug screen based on cell cycle uncoupling does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer drug screen based on cell cycle uncoupling, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer drug screen based on cell cycle uncoupling will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1213466